Ergostatrien-3β-ol suppresses breast cancer anoikis resistance and metastasis by targeting the miR-93-5p/leupaxin axis. - Rengamanar H; Chen WC; Kuo YH; Tsai HC; Fong YC; Guo JH; Liu CL; Huang TM; Wu CY; Tang CH (European journal of pharmacology, 2026)